Analystreport

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target lowered by analysts at Wedbush from $32.00 to $24.00. They now have an "outperform" rating on the

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report